Adlai Nortye ANL
NASDAQ ANL
$15.65 +0.25 (+1.62%)
At close: Sep 29, 2026 · 4:00 PM EDT

Adlai Nortye (ANL) Total Debt (2022 - 2026)

Updated

Adlai Nortye (ANL) posted Total Debt of $24.96 million for Q2 2026, down 43.3% from $44.05 million a year earlier.

Analysis

Adlai Nortye (ANL) Total Debt (2022 - 2026) Analysis & Trends

At the end of FY2025, Adlai Nortye's Total Debt came in at $24.58 million, down 6.6% from FY2024.

  • Annual Total Debt has declined for three consecutive years, with a three-year compound annual growth rate of -56.3% (FY2022 to FY2025).
  • In prior years, Adlai Nortye's Total Debt was $26.33 million in FY2024 (-13.3%), $30.36 million in FY2023 (-89.7%) and $294.68 million in FY2022.
  • Quarterly Total Debt has run from a low of -$602,000 in Q4 2023 to a high of $290.08 million in Q4 2022 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 49.04 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 70.82 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 53.91 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 37.49 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -111.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 57.30 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 26.25 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 63.19 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Adlai Nortye 528.79 Mn 429.49 Mn - 24.96 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 24.96 Mn
Dec 31, 2025 24.58 Mn
Jun 30, 2025 44.05 Mn
Dec 31, 2024 26.33 Mn
Jun 30, 2024 38.89 Mn
Dec 31, 2023 -602,000.00
Dec 31, 2022 290.08 Mn
API Access

Adlai Nortye Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=ANL&period=max&api_key=YOUR_API_KEY